These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29781567)

  • 1. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
    Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Lautz TB; Xue W; Luo LY; Fair D; Qumseya A; Gao Z; Dasgupta R; Rodeberg D; Venkatramani R
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30357. PubMed ID: 37070563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
    De Salvo GL; Del Bianco P; Minard-Colin V; Chisholm J; Jenney M; Guillen G; Devalck C; Van Rijn R; Shipley J; Orbach D; Kelsey A; Rogers T; Guerin F; Scarzello G; Ferrari A; Cesen Mazic M; Merks JHM; Bisogno G;
    Cancer; 2024 Jul; 130(13):2351-2360. PubMed ID: 38400828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Dietzschold M; Schönstein A; Heinz A; Vokuhl C; Pajtler KW; Harrabi S; Lin YL; Kalle TV; Hagen R; Ladenstein R; Kazanowska B; Ljungman G; Klingebiel T; Ebinger M; Koscielniak E; Münter M; Timmermann B;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30742. PubMed ID: 37880926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
    Bisogno G; Fuchs J; Dasgupta R; Ferrari A; Haduong JH; Rogers T; Walterhouse DO; Coppadoro B; Xue W; Vokuhl C; Hawkins DS; Seitz G; Merks JHM; Sparber-Sauer M; Venkatramani R
    Cancer; 2022 Dec; 128(23):4150-4156. PubMed ID: 36250420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Ermoian RP; Breneman J; Walterhouse DO; Chi YY; Meza J; Anderson J; Hawkins DS; Hayes-Jordan AA; Parham DM; Yock TI; Donaldson SS; Wolden SL
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28548706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
    Slater O; Gains JE; Kelsey AM; De Corti F; Zanetti I; Coppadoro B; Jorgensen M; Gallego S; Orbach DH; Glosli H; Cesen M; Gaze MN; Smeulders N; Ferrari A; Jenney M; Minard-Colin V; Bisogno G; Merks JHM;
    Eur J Cancer; 2022 Jan; 160():206-214. PubMed ID: 34865946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma: A Retrospective Single-Center Study From China.
    Peng X; Xiong X; Li Y; Li C; Wang Z; Wu Y; Su M; Weng W; Huang K; Zhou D; Fang J
    Cancer Control; 2024; 31():10732748241240655. PubMed ID: 38514935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry.
    Koscielniak E; Timmermann B; Münter M; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Brecht IB; Blank B; Hallmen E; Scheer M; Fuchs J; Seitz G; Blattmann C; Sparber-Sauer M; Klingebiel T
    J Clin Oncol; 2023 Nov; 41(31):4916-4926. PubMed ID: 37725766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group.
    Metts J; Xue W; Gao Z; Ermoian R; Bradley JA; Arnold MA; Dasgupta R; Venkatramani R; Walterhouse D
    Cancer; 2023 Jun; 129(11):1735-1743. PubMed ID: 36857314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Vasquez JC; Luo LY; Hiniker SM; Rhee DS; Dasgupta R; Chen S; Weigel BJ; Xue W; Venkatramani R; Arndt CA
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30293. PubMed ID: 36916768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines.
    Dávila Fajardo R; Scarzello G; Gaze MN; Boterberg T; Cameron A; Fuchs J; Guérin F; Hoskin P; Krasin MJ; Kroon P; Magelssen H; Mercke C; Merks JHM; Paulsen F; Pommier P; Ramos M; Rees H; Rogers T; Schmid M; Seitz G; Slater O; Smeulders N; Stenman J; Terwisscha S; Chargari C; Mandeville HC
    Radiother Oncol; 2024 Jun; 195():110273. PubMed ID: 38588921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.
    Schloemer NJ; Xue W; Qumseya A; Luo LY; Hiniker SM; Lautz TB; Rhee DS; Arnold MA; Venkatramani R
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30701. PubMed ID: 37783659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.
    Oberoi S; Qumseya A; Xue W; Venkatramani R; Weiss AR
    Cancer; 2024 Jul; 130(14):2493-2502. PubMed ID: 38470405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics, treatment, prognosis and pregnancy outcomes in rhabdomyosarcoma of the uterine cervix: a case series.
    Yu X; Qie M; Huang L; Hou M
    Ginekol Pol; 2023 Dec; ():. PubMed ID: 38126889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.
    Peinemann F; Kröger N; Bartel C; Grouven U; Pittler M; Erttmann R; Kulig M
    PLoS One; 2011 Feb; 6(2):e17127. PubMed ID: 21373200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.
    Metts J; Xue W; Gao Z; Oberoi S; Weiss AR; Venkatramani R; Harrison DJ
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31009. PubMed ID: 38627882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival.
    Zhao D; Zhou F; Liu W; Huang Z; Xu X; Zheng B; Liu C; Bai C; Liu J; Sun Y; Wang W; Xiao S
    BMC Cancer; 2024 Mar; 24(1):340. PubMed ID: 38486204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.